Immunogenicity and Efficacy of Pneumococcal Conjugate Vaccine (Prevenar13®) in Preventing Acquisition of Carriage of Pneumococcal Vaccine Serotypes in Tanzanian Children With HIV/AIDS

Immunogenicity and Efficacy of Pneumococcal Conjugate Vaccine (Prevenar13®) in Preventing Acquisition of Carriage of Pneumococcal Vaccine Serotypes in Tanzanian Children With HIV/AIDS

In every year, up to one million children die due to pneumococcal disease. Children infected with Human Immunodeficiency Virus (HIV) are mostly affected, as they appear to have higher rates of pneumococcal carriage and invasive disease. Successful immunity is dependent on mounting a sufficient immun...

Full description

Bibliographic Details
Main Authors: Geofrey Makenga, George Mtove, J. Kevin Yin, Abubakary Mziray, Veneranda M. Bwana, William Kisinza, Julius Mjema, Ben Amos, Laura Antony, Delane Shingadia, Shahin Oftadeh, Robert Booy
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Immunology
Subjects:
immunogenicity
efficacy
Prevenar 13
carriage acquisition
immunocompromised children
prevention
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.673392/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.673392/full

Similar Items